OMCL - Omnicell Inc Stock Price, Fair Value and News

$40.50+2.04 (+5.30%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

OMCL Price Action

Last 7 days

10.5%

Last 30 days

21.4%

Last 90 days

22.3%

Trailing 12 Months

-13.6%

OMCL RSI Chart

OMCL Valuation

Market Cap

1.8B

Price/Earnings (Trailing)

91.24

Price/Sales (Trailing)

1.54

EV/EBITDA

14.07

Price/Free Cashflow

16.31

OMCL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

OMCL Fundamentals

OMCL Revenue

Revenue (TTM)

1.2B

Rev. Growth (Yr)

9.99%

Rev. Growth (Qtr)

6.91%

OMCL Earnings

Earnings (TTM)

19.9M

Earnings Growth (Yr)

-36.71%

Earnings Growth (Qtr)

-3.14%

OMCL Profitability

Operating Margin

83.15%

EBT Margin

2.91%

Return on Equity

1.63%

Return on Assets

1.02%

Free Cashflow Yield

6.13%

OMCL Investor Care

Buy Backs (1Y)

3.11%

Diluted EPS (TTM)

0.43

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	1.1B	1.1B	1.2B	0
2024	1.1B	1.1B	1.1B	1.1B
2023	1.3B	1.2B	1.2B	1.1B
2022	1.2B	1.3B	1.3B	1.3B
2021	914.4M	987.5M	1.1B	1.1B
2020	924.2M	906.4M	891.3M	892.2M
2019	807.2M	835.9M	860.5M	897.0M
2018	746.8M	754.4M	771.9M	787.3M
2017	673.5M	681.6M	691.6M	712.7M
2016	539.3M	599.5M	651.0M	695.9M
2015	455.4M	463.1M	475.8M	484.6M
2014	395.2M	406.6M	425.1M	440.9M
2013	337.0M	355.3M	365.0M	380.6M
2012	252.5M	266.9M	286.8M	314.0M
2011	225.4M	231.7M	239.9M	245.5M
2010	0	0	0	222.4M

Get all data in R, Python etc through our Historical Stock Data APIs

About Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.

CEO	Mr. Randall A. Lipps
WEBSITE	omnicell.com
SECTOR	Healthcare
INDUSTRY	Health Information Services
EMPLOYEES	3780

Omnicell Inc Frequently Asked Questions

What is the ticker symbol for Omnicell Inc? What does OMCL stand for in stocks?

OMCL is the stock ticker symbol of Omnicell Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Omnicell Inc (OMCL)?

As of Wed Dec 03 2025, market cap of Omnicell Inc is 1.82 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OMCL stock?

You can check OMCL's fair value in chart for subscribers.

Is Omnicell Inc a good stock to buy?

The fair value guage provides a quick view whether OMCL is over valued or under valued. Whether Omnicell Inc is cheap or expensive depends on the assumptions which impact Omnicell Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OMCL.

What is Omnicell Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, OMCL's PE ratio (Price to Earnings) is 91.24 and Price to Sales (PS) ratio is 1.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OMCL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Omnicell Inc's stock?

In the past 10 years, Omnicell Inc has provided 0.029 (multiply by 100 for percentage) rate of return.